-
Eight faculty members recently graduated from UAB Medicine’s LEading Advancing Developing (LEAD) Fall 2024 leadership development program. The program, presented by UAB Medicine’s Leadership Development Office (LDO), recognized its graduates at a ceremony on Oct. 24, 2024.
-
Graduate Biomedical Sciences (GBS) at UAB recently welcomed its new class of GBS students pursuing their Ph.D. across eight interdisciplinary training themes. The GBS Doctoral Training Program provides interdisciplinary education and mentorship while allowing GBS trainees to perform doctoral research[…]
-
Blazer BRAIN is an eight-week undergraduate summer program that offers students an opportunity to conduct research and participate in an intensive professional development program as they work towards earning their Ph.D. in neuroscience.
-
On Friday, Nov. 17, 2023, students from Heersink School of Medicine gathered to celebrate faculty, courses, and course directors at the annual Argus Awards Ceremony.
-
Twelve faculty have been selected to receive the President’s Award for Excellence in Teaching, which honors those who have demonstrated exceptional accomplishments in teaching. The 2023 honorees represent each school, the College of Arts and Sciences, the Honors College, and[…]
-
FASEB is the largest coalition of biological and biomedical research associations in the United States and advocates for basic biomedical research.
-
In the last several years, UAB Medicine and Heersink School of Medicine have worked to bring leadership development to faculty and staff through the UAB Medicine Institute for Leadership and Momentum in Medicine programs.
-
Mechanistic findings in this study may pave the way for future time-restricted feeding studies in muscle, providing a natural and affordable form of alternative therapy for managing pathologies related to metabolism and obesity.
-
FASEB is the largest coalition of biological and biomedical research associations in the United States.
-
The drug inhibits the kinase Cdk5, found in mature neurons. Cdk5 has long been implicated in neuropsychiatric and neurodegenerative conditions, but previous inhibitors have largely failed to reach the brain through the blood-brain barrier.
